STAT Plus: After a pharma lobbying blitz, Congress softens legislation on drug patents
WIN MCNAMEE/GETTY IMAGES
Pharmaceutical companies appear to have succeeded in watering down legislation that would've made it harder for them to accumulate patents.
No hay comentarios:
Publicar un comentario